Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03376475
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
BUL | BULGECIN A | A | 1LMC | 0.78 | |
BUL | BULGECIN A | A | 1LSP | 0.78 | |
SNG | METHYL 2-ACETAMIDO-1,2-DIDEOXY- 1-SELENO-BETA-D-GLUCOPYRANOSIDE | A | 2BWM | 0.7 | |
SNG | METHYL 2-ACETAMIDO-1,2-DIDEOXY- 1-SELENO-BETA-D-GLUCOPYRANOSIDE | A | 1O9V | 0.7 | |
MLD | GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)- L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA | A,X | 2F2L | 0.71 | |
MLD | GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)- L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA | A,B,C,D | 2CB3 | 0.71 | |
WZ4 | methyl 2-(acetylamino)-2-deoxy- beta-D-glucopyranosyl-(1->2)-alpha- D-mannopyranosyl-(1->3)-[alpha- D-mannopyranosyl-(1->6)-6-thio- alpha-D-mannopyranosyl-(1->6)]- beta-D-mannopyranoside | A | 3BVW | 0.72 | |
MA8 | (2S,3R,5S,6S)-2,3,4,5,6-PENTAHYDROXYCYCLOHEXYL 2- (L-CYSTEINYLAMINO)-2-DEOXY-ALPHA- L-GLUCOPYRANOSIDE | A | 2C27 | 0.75 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3I | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 1KQR | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B,C,D,E,F | 1HGH | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B | 2I2S | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3J | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B,C,D,E,F | 1HGE | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3K | 0.7 | |
DT6 | 2,4-BIS(ACETYLAMINO)-1,5-ANHYDRO- 2,4-DIDEOXY-D-GLUCITOL | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R | 2HIL | 0.7 | |
DT6 | 2,4-BIS(ACETYLAMINO)-1,5-ANHYDRO- 2,4-DIDEOXY-D-GLUCITOL | A | 2HI2 | 0.7 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A | 1ZT4 | 0.7 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A,C,E | 2PO6 | 0.7 | |
PBS | (2S,3S,4R)-N-OCTANOYL-1-[(ALPHA- D-GALACTOPYRANOSYL)OXY]-2-AMINO- OCTADECANE-3,4-DIOL | A,C | 1Z5L | 0.7 | |
NXD | METHYL 5-(ACETYLAMINO)-9-{[AMINO(OXO)ACETYL]AMINO}- 3,5,9-TRIDEOXY-D-GLYCERO-ALPHA- D-GLUCO-NON-2-ULOPYRANOSIDONIC ACID | A | 2G5R | 0.75 | |
2G0 | (2S)-1-[(2S)-6-amino-2-({[(2S,3S,4R,5S,6S)- 3,4,5-trihydroxy-6-methyltetrahydro- 2H-pyran-2-yl]acetyl}amino)hexanoyl]- N-[(1S)-1-carbamoyl-3-methylbutyl]pyrrolidine- 2-carboxamide | A,B,C,D | 3DCQ | 0.74 | |
SKD | 2-ACETYLAMINO-7-(1,2-DIHYDROXY- ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE- 5-CARBOXYLIC ACID | A | 2SLI | 0.71 | |
SKD | 2-ACETYLAMINO-7-(1,2-DIHYDROXY- ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE- 5-CARBOXYLIC ACID | A | 2JKB | 0.71 | |
SKD | 2-ACETYLAMINO-7-(1,2-DIHYDROXY- ETHYL)-3-HYDROXY-6,8-DIOXA-BICYCLO[3.2.1]OCTANE- 5-CARBOXYLIC ACID | A | 3SLI | 0.71 | |
AMN | 9-DEOXY-9-AMINO-2-O-METHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGJ | 0.71 | |
ANA | 4-O-ACETYL-ALPHA-2-OMETHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGI | 0.7 | |
SIO | methyl 4,9-di-O-acetyl-5-(acetylamino)- 3,5-dideoxy-D-glycero-alpha-D-galacto- non-2-ulopyranosidonic acid | A | 3CL5 | 0.71 | |
CLY | CLINDAMYCIN | 0,1,3,9,A,B, C,H,J,K,L,M, N,O,Q,R,S,T, U,Y,Z | 1YJN | 0.83 | |
CLY | CLINDAMYCIN | A | 1JZX | 0.83 | |
HAG | 4-S-GLUTATHIONYL-5-PENTYL-TETRAHYDRO- FURAN-2-OL | A,B | 1B48 | 0.77 | |
PCJ | (2R)-3-{[(2S)-3-HYDROXY-2-(PALMITOYLAMINO)PROPYL]THIO}PROPANE- 1,2-DIYL DIHEXADECANOATE | A,N | 2Z81 | 0.72 | |
PCJ | (2R)-3-{[(2S)-3-HYDROXY-2-(PALMITOYLAMINO)PROPYL]THIO}PROPANE- 1,2-DIYL DIHEXADECANOATE | A,B,C | 2Z7X | 0.72 | |
BLG | 4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)- 5-METHYLHYDROXY-L-PROLINE-TAURINE | A | 1D0M | 0.78 | |
BLG | 4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)- 5-METHYLHYDROXY-L-PROLINE-TAURINE | A | 1D0L | 0.78 | |
BLG | 4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)- 5-METHYLHYDROXY-L-PROLINE-TAURINE | A | 1SLY | 0.78 | |
MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXV | 0.72 | |
MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXU | 0.72 | |
8GP | A | 2F3U | 0.7 | ||
BGN | N-BUTANOYL-2-AMINO-2-DEOXY-GLUCOPYRANOSIDE | A,B,C,D | 1NWG | 0.7 |